· Global leader in medical imaging analysis Quibim has joined Highlight Therapeutics, a clinical-stage company specializing in immuno-oncology, to assess…
Read More
World Osteoporosis Day (WOD) is here. This October 20th gives us an excellent opportunity to reflect on the millions of people affected…
Read More
There is currently no effective cure for this virus and there is an urgent need to increase global knowledge in…
Read More
For the third consecutive year, and coinciding with our business expansion, currently installed in more than 60 hospitals and used by…
Read More
Taking part in the EU’s H2020 initiative translated into huge strides in disease detection and diagnosis by QUIBIM, by enabling…
Read More
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical imaging…
Read More
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a…
Read More
Chest X-ray classifier is added as a new CE cleared tool within Quibim Precision® platform, which already received CE mark…
Read More
As the first ESMO Breast Cancer Congress unfolded 2-4 May in Berlin, Germany, QUIBIM CEO highlighted the role played by…
Read More
Integrating artificial intelligence (AI) into the radiologist’s workflow is still challenging, but all-inclusive solutions can help unfold algorithms’ power, QUIBIM…
Read More
